Navigation Links
Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril

us

Thiazide diuretics have been reported to cause exacerbation or activation of systemic lupus erythematosus.

    Lithium Interaction

    Lithium generally should not be given with thiazides.

Adverse Events

In clinical trials, the withdrawal rates due to adverse events (AEs) were similar with BENICAR and BENICAR HCT to placebo: BENICAR (2.4 percent vs 2.7 percent); BENICAR HCT (2.0 percent vs 2.0 percent). The incidence of AEs with BENICAR and BENICAR HCT were similar to placebo. The only AE that occurred in >1 percent of patients treated with BENICAR and more frequently than placebo was dizziness (3 percent vs 1 percent). AEs reported in >2 percent of patients taking BENICAR HCT and more frequently than placebo included nausea (3 percent vs 0 percent), hyperuricemia (4 percent vs 2 percent), dizziness (9 percent vs 2 percent), and upper respiratory tract infection (7 percent vs 0 percent).

No initial dosage adjustments are recommended with BENICAR in elderly, in moderate to marked renal impairment (creatinine clearance <40 mL/min), or in hepatic dysfunction. In patients with possible depletion of intravascular volume (e.g., patients on diuretics, particularly with impaired renal function), BENICAR should be initiated under close medical supervision and consideration given to use of a lower starting dose. For BENICAR HCT, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosage range.

Please see full prescribing information for BENICAR and BENICAR HCT.

Both products are co-promoted in the United States by Daiichi Sankyo, Inc. and Forest Laboratories, Inc.

About Daiichi Sankyo

Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd., Japan's second largest pharmaceutical company and a global leader in pharmaceutical innovation since 1899. The company is dedicated to the discovery, development an
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
2. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
3. Byetta Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
4. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
5. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
6. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
7. Lipitor Provides Unprecedented Cardiovascular Risk Reductions in Diabetes Patients with Metabolic Syndrome and in Stroke Patients
8. Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies
9. Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
10. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
11. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes

Post Your Comments:
(Date:12/2/2009)..., Dec. 2 Keryx Biopharma...hat the U.S. Food and Drug Administration (FDA) ha...ifosine), the Company,s novel, potentially first-i...phosphoinositide 3-kinase (PI3K)/Akt pathway, for ...oma. ,, The Fast Track program of the FDA is ...
(Date:12/2/2009)... Ala., Dec. 2 Adults are more li...ancer. For adults 65 and over, the odds of losing ... developing prostate cancer are one in six and odd...ine. Vision loss threatens the overall health of ...epression and inability to complete daily tasks. ,...
(Date:12/2/2009)...JO, Calif., Dec. 2 Clari...nd services resource for pathologists, oncologists...a Chief Financial Officer transition plan that cal...iguez to become its Senior Vice President and Chie.... Land, age 64, the current Senior Vice President ...
Breaking Medicine Technology:Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4Risk of Vision Loss in Aging Adults is Greater Than Risk of Breast or Prostate Cancer 2Clarient Announces CFO Transition Plan 2Clarient Announces CFO Transition Plan 3Clarient Announces CFO Transition Plan 4Office Zone Adds New Paper Shredder Resources Section To Its Site 54012 1Office Zone Adds New Paper Shredder Resources Section To Its Site 54012 2New Online Tutorial for iHOP from OpenHelix 54008 1New Online Tutorial for iHOP from OpenHelix 54008 2New Online Tutorial for iHOP from OpenHelix 54008 3BIO key 28R 29 Announces Second Quarter Conference Call Schedule 9524 1BIO key 28R 29 Announces Second Quarter Conference Call Schedule 9524 2
...2007 /PRNewswire/ -- Treatment of,coronary artery ...,inpatient setting, according to a study published...S. hospitalization rates for heart attacks (acute ... 2002 to 2005, possibly due,to broader use of prev..., as well as declines in risk factors like smoking...
...Studies Presented at the Targeted,Anticancer Thera...r,Targets for Cancer Meetings Support Phase 1 Tria...007,/PRNewswire-FirstCall/ -- Sunesis Pharmaceutic...elopment-stage compound, SNS-314, at,two leading s...medicines. Findings from in vitro and in vivo stud...
Other Medicine Technology:Hospitalization Rates for Coronary Artery Disease Decline in the,U.S. 2Hospitalization Rates for Coronary Artery Disease Decline in the,U.S. 3Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor,Data Showing Broad Anti-Tumor Activity, Dosing Flexibility 2Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor,Data Showing Broad Anti-Tumor Activity, Dosing Flexibility 3
(Date:12/2/2009)... , KNOXVILLE, Tenn., Dec. 2 Te...ce in Southwest Florida with the acquisition of Na...N). Since January 2002, EPN has held an exclusive...emergency facilities at the Downtown Naples Hospit...e Clinic. EPN also provides the staffing for two s...
(Date:12/2/2009)...ham, MAJoseph Balboni loves sports. An avid tennis...6-year-old insurance agent became increasingly fru...ratoconus, a degenerative eye disorder. Unable to ... games, he faced the prospect of a corneal transpl...n three years ago, Balboni discovered an alternati...
(Date:12/2/2009)...ECHO 2009 is the official congress of the European...ed branch of the European Society of Cardiology, w... will be presented. , New case reports will be ... evidence highlighting the role of this new techno...ging techniques, it is likely that non-invasive im...
(Date:12/2/2009)... National Pen ( www.pens.com ),..., announced today it is giving away 10,000 free bu...B) December 2, 2009 -- National Pen ( www.pens.com...ler announced today it is giving away 10,000 free ... way to promote business that no other company in ...
(Date:12/2/2009)... Revolutionary new cell phones ...om users will be available in early 2010 from Aeri...(PRWEB) December 2, 2009 -- Revolutionary new cell... away from users will be available in early 2010 f...ecently honored with a Green Technology Award in w...
Breaking Medicine News(10 mins):Health News:TeamHealth Acquires Emergency Physicians of Naples, LLC 2Health News:Brandeis studies evaluate visionary approach to improving eyesight 2Health News:Media alert: EUROECHO 2009 2Health News:National Pen Giving Away 10,000 Business Card Pens 2Health News:New AERIUS Cell Phones Direct Microwave Signals Away from Users 2
...fi-aventis announced today that Jean-Pierre Leh...hief Medical Officer (CMO). He was previously Sen...rs. , , Jean-Pierre Lehner reports to Marc Cluzel...ally and externally of the company,s commitment to...
.... 11 Dr. Doran Edwards is the former,Medical Dire...quipment,Regional Carrier (SADMERC), the division ... until August of 2008. He believes that Medicare i...,costly home environment. Unfortunately, the preva...
... 11 The Quantum Group, Inc. ( NYSE Alternext US: ...ete Martinez, Senior Vice President and Chief Tech... to participate with the St. Thomas University H... a panelist along with executives from leading are...
...esterol Screening Locator Launched , , CINCINNATI...t survey, the majority of American women don,t kno... every three women are at risk for heart disease(2..., Metamucil and WomenHeart, the nation,s only nati...
...ent Coach Wendy Lewis Explains the New Face of Fru...y expert and leading image enhancement coach Wendy... cosmetic enhancements and anti-aging beauty treat...s tough economy, Lewis, who opened Wendy Lewis &am...
...eb. 11 With a strong corporate commitment to edu...ay its partnership with the American Pregnancy Ass...ic Naturals as the "the official omega-3" of their...roductive and pregnancy wellness through education...
Other Medicine News:Health News:Jean-Pierre Lehner Appointed Chief Medical Officer 2Health News:Former Medical Director Speaks Out About Medicare Fraud 2Health News:Former Medical Director Speaks Out About Medicare Fraud 3Health News:Quantum Executive Pete Martinez Invited to Participate in University Health Seminar 2Health News:Quantum Executive Pete Martinez Invited to Participate in University Health Seminar 3Health News:Quantum Executive Pete Martinez Invited to Participate in University Health Seminar 4Health News:Metamucil(R), WomenHeart and 'Desperate Housewives' Star Brenda Strong Partner to Encourage 100,000 Women to Lower Their Cholesterol 2Health News:Metamucil(R), WomenHeart and 'Desperate Housewives' Star Brenda Strong Partner to Encourage 100,000 Women to Lower Their Cholesterol 3Health News:Metamucil(R), WomenHeart and 'Desperate Housewives' Star Brenda Strong Partner to Encourage 100,000 Women to Lower Their Cholesterol 4Health News:Metamucil(R), WomenHeart and 'Desperate Housewives' Star Brenda Strong Partner to Encourage 100,000 Women to Lower Their Cholesterol 5Health News:Your Finances or a Facelift? It's Time to Downsize 2Health News:Nordic Naturals Becomes the Official Omega-3 of the American Pregnancy Association 2
MAMMOMAT 3000 Nova Mammography System
ActiveLife® One-Piece Cut-to-Fit Urostomy Pouch With Stomahesive® Skin Barrier
Contour I Drainable Pouch, Oval Cut-to-Fit Skin Barrier
Karaya 5 Drainable Pouch, 9in., (23cm)
Medicine Products: